Monday Apr 14
UPDATE 1-Akorn gets U.S. approval to buy Hi-Tech Pharmacal, with conditions
Generic drugmaker Akorn Enterprises Inc has won U.S. antitrust approval to buy rival Hi-Tech Pharmacal Inc on condition that it sell three generic prescription eye medications and two generic topical anesthetics, the Federal Trade Commission said on Monday.
Shire Development, LLC v. Watson Pharmaceuticals, Inc.
Claim construction in patent cases, and the propensity for the Federal Circuit to disagree with a district court's conclusions regarding the scope and meaning of claim terms, remains one of the most vexing aspects of patent litigation .
Half of U.S. adults ages 40 to 75 are eligible for cholesterol-lowering drugs
This 2011 photo provided by Watson Pharmaceuticals Inc. shows bottles of Atorvastatin calcium tablets, a generic form of Lipitor that is sold under a deal with Pfizer.
U.S. wants at least $1 billion from drugmakers who delay generics
The U.S. Federal Trade Commission seeks a settlement of $1 billion or more from pharmaceutical companies it has sued for delaying the sale of cheaper medicines after patents on brand-name drugs may have expired, an FTC official told a legal conference on Friday.
Half of US adults 40 to 75 eligible for statins
This 2011 photo provided by Watson Pharmaceuticals Inc. shows bottles of Atorvastatin Calcium tablets, a generic form of Lipitor which is sold under a deal with Pfizer.